research report      name index      key word index      corresp.unit            Page in german   

Third-party-funded project

Title:
Mechanisms of antigen-specific therapy of EAN with oligomeric peptides

Project management at the University of Würzburg:

Participating scientists:

Abstract:
This project will focus on mechanisms of action of oligomeric peptide therapy in EAN, in particular induction of regulatory CD25+ T cells. After vaccination with oligomeric peptides regulatory T cells subsets will be further characterized in co-transfer experiments, in conjunction with costimulation by CD28/CTLA-4. Neuritogenic T cells will be tracked by using the GFP (green fluorescent protein) system. By cDNA microarray and quantitative PCR further molecular mechanisms will be assessed. Ultimately this project is meant to develop new therapeutic approaches for Guillain-Barré-syndrome.

Key words:
    T cells
    altered peptide ligands
    EAN

Projekt period: from 02.2002 to 01.2004

Funding institution:
Sonstige Stiftung ( Gemeinnützige Hertie-Stiftung (GHS) ) ,Granting date: 12.02.2002

Publications: